Medicure (MCUJF) Cash from Investing Activities (2010 - 2026)
Medicure (MCUJF) posted quarterly Cash from Investing Activities of -$278556.6 for Q1 2026, up 26.25% year-over-year from -$220630.4 in Q1 2025, and down 387.75% quarter-over-quarter from $96806.6 in Q4 2025.
Medicure (MCUJF) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Medicure's Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$278556.6 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 26.25% year-over-year to -$278556.6; the TTM figure through Mar 2026 stood at -$1.4 million (down 60.63% YoY), while the FY2025 annual figure was -$1.5 million, down 170.77% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$278556.6, down from $96806.6 in the prior quarter.
- The five-year high for Cash from Investing Activities was $96806.6 in Q4 2025, with the low at -$1.2 million in Q2 2025.
- The 5-year median for Cash from Investing Activities is -$89901.3 (2023), against an average of -$203051.1.
- Peak annual rise in Cash from Investing Activities reached 130.19% in 2025, while the deepest fall reached 1451.84% in 2025.
- Medicure's Cash from Investing Activities stood at -$206254.7 in 2022, then surged by 54.42% to -$94020.5 in 2023, then sank by 241.1% to -$320700.4 in 2024, then surged by 130.19% to $96806.6 in 2025, then plunged by 387.75% to -$278556.6 in 2026.
- Business Quant data shows MCUJF's Cash from Investing Activities at -$278556.6 in Q1 2026, $96806.6 in Q4 2025, and -$1.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | -278,556.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278,556.57 |
| Mar 31, 2026 | -278,556.57 |
| Dec 31, 2025 | 96,806.65 |
| Dec 31, 2025 | 96,806.65 |
| Jun 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Mar 31, 2025 | -377,728.73 |
| Mar 31, 2025 | -377,728.73 |
| Dec 31, 2024 | -320,700.41 |
| Dec 31, 2024 | -320,700.41 |
| Sep 30, 2024 | -73,305.34 |
| Sep 30, 2024 | -73,305.34 |
| Jun 30, 2024 | -76,038.62 |
| Jun 30, 2024 | -76,038.62 |
| Mar 31, 2024 | -64,563.85 |
| Mar 31, 2024 | -64,563.85 |
| Dec 31, 2023 | -94,020.55 |
| Dec 31, 2023 | -94,020.55 |
| Sep 30, 2023 | -85,782.00 |
| Sep 30, 2023 | -85,782.00 |